Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precuneus Mapping With Sinaptistim® (an Investigational TMS-EEG System) in Mild to Moderate AD Patients

NCT07841808 is registered in ClinicalTrials.gov with Sinaptica Therapeutics, Inc. as lead sponsor.

NCT NCT07841808
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07841808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precuneus Mapping With Sinaptistim® (an Investigational TMS-EEG System) in Mild to Moderate AD Patients
Lead sponsor
Sinaptica Therapeutics, Inc.
Phase
Observational
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
April 30, 2027
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer s disease